1. Investigating the Roleof Metal Chelation in HIV-1Integrase Strand Transfer Inhibitors.
- Author
-
Alessia Bacchi, Mauro Carcelli, Carlotta Compari, Emilia Fisicaro, Nicolino Pala, Gabriele Rispoli, Dominga Rogolino, Tino W. Sanchez, Mario Sechi, Valentina Sinisi, and Nouri Neamati
- Subjects
- *
PHARMACEUTICAL research , *CHELATES , *INTEGRASES , *ENZYME inhibitors , *HIV infections , *THERAPEUTICS , *TARGETED drug delivery - Abstract
HIV-1 integrase (IN) has been validated as an attractivetargetfor the treatment of HIV/AIDS. Several studies have confirmed thatthe metal binding function is a crucial feature in many of the reportedIN inhibitors. To provide new insights on the metal chelating mechanismof IN inhibitors, we prepared a series of metal complexes of two ligands(HL1and HL2), designed as representative modelsof the clinically used compounds raltegravir and elvitegravir. Potentiometricmeasurements were conducted for HL2in the presence ofMg(II), Mn(II), Co(II), and Zn(II) in order to delineate a metal speciationmodel. We also determined the X-ray structures of both of the ligandsand of three representative metal complexes. Our results support thehypothesis that several selective strand transfer inhibitors preferentiallychelate one cation in solution and that the metal complexes can interactwith the active site of the enzyme. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF